Jinhua qinggan granules for non-hospitalized covid-19 patients: a double-blind, placebo-controlled, and randomized controlled trial

HIGHLIGHTS

• who: Muhammad Raza Shah and collaborators from the Yasuj University of Medical Sciences, Iran have published the Article: Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial, in the Journal: (JOURNAL) of September/22,/2020
• what: This clinical trial was aimed to evaluate the efficacy and safety of JHQG in non-hospitalized Pakistani COVID-19 patients with mild disease. tests and patients' conditions as per the seven-category ordinal scale. The authors demonstrated that JHQG was a safe and effective TCM for the symptomatic relief of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.